May 31, 2026
Dividend Stocks

Escape the META Matrix: Why Investors Should Sell Now

Source: rafapress / Shutterstock.com On March 13, the U.S. House passed a bill that would ban TikTok, the Chinese-owned social media app, if it’s not sold.The move came over the objection of former President Trump, who instead called Meta Platforms (NASDAQ:META) “the enemy of the people.” This will have big implications for META stock holders. […]

Read More
Dividend Stocks

The 3 Most Undervalued E-Commerce Stocks to Buy in March 2024

The e-commerce trend continues to take share from traditional retail. Statista estimates a 9.79% compounded annual growth rate in worldwide e-commerce revenues between 2024 and 2029. Therefore, we are in the early innings of this shift and undervalued e-commerce stocks will outperform. Several reasons exist for the momentum in e-commerce growth. First, e-commerce’s value proposition […]

Read More
Dividend Stocks

Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With

Generally speaking, you want to minimize your exposure to cheap stocks under $10. Yes, smaller companies have the potential to rise dramatically higher than their larger counterparts. In part, that’s because they’re unpredictable – and this ambiguity cuts both ways. Sure, cheap stocks under $10 have the benefit of the law of small numbers working […]

Read More
Investing

Top Wall Street analysts prefer these three stocks for the long haul

In this photo illustration, the CrowdStrike Holdings, Inc. logo is displayed on a smartphone screen.  Rafael Henrique | SOPA Images | Lightrocket | Getty Images Investors’ worries about the prospect of higher-for-longer interest rates have made a comeback, pulling the major averages lower this past week. Even as markets seem turbulent for now, it’s key […]

Read More
Dividend Stocks

Don’t Write Off Intel Just Yet: The Bull Case for INTC Stock

Wednesday’s trading session provided some serious doubt for investors in Intel (NYSE:INTC) stock after the Pentagon withdrew its $2.5 billion chip grant for the company. The decline brought INTC stock down 3%, and has some investors questioning whether this is a chip stock to buy right now. This decision could reduce federal funding for Intel […]

Read More
Dividend Stocks

Two Different Flavors of Biotech 

The biotech sector, in particular, is offering a compelling and timely opportunity. Hello, Reader.  A polarizing debate has long plagued the nation, even the world… Which flavor is better, chocolate or vanilla? Hard stances are usually taken. Chocolate lovers never bend, and vanilla enthusiasts remain, well, enthusiastic. I myself am a hard-core vanilla guy. When […]

Read More
Dividend Stocks

The Clock is Ticking: 3 Stocks Set to Explode in the Next Quarter The Clock is Ticking: 3 Stocks Set to Explode in the Next Quarter

Finding the next great investment is alluring, almost like a siren’s song. For this, one must possess a crystal ball to identify the stocks about to soar, elevating portfolios to unprecedented heights. Ok, let’s set aside the crystal ball. Let’s dive into three titans in their own fields with stories full of potential and promise. […]

Read More
Dividend Stocks

MSFT Stock Forecast: 3 Explosive Reasons to Own Microsoft Now

Microsoft (NASDAQ:MSFT) Copilot now offers GPT-4 Turbo for free. I don’t know what that means for MSFT stock, but it shows the company’s commitment to AI. CNET contributor Don Reisinger points out that the move is a sign OpenAI is likely close to launching GPT-4.5 Turbo, which would be for Copilot Pro users who pay […]

Read More
Dividend Stocks

Three Reasons Why the U.S. is an Oasis for Investors

I want to talk about why the U.S. is an oasis. In the wake of Super Tuesday, it is now clear that the election will be a rematch between former President Donald Trump and current President Joe Biden. You can bet that temperatures will rise as we approach the election. Meanwhile, there are a lot […]

Read More
Dividend Stocks

CLDI Stock Earnings: Calidi Biotherapeutics Misses EPS for Q4 2023

Source: iQoncept / Shutterstock Calidi Biotherapeutics (NYSEMKT:CLDI) just reported results for the fourth quarter of 2023. Calidi Biotherapeutics reported earnings per share of -23 cents. This was below the analyst estimate for EPS of -20 cents. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that leverages data from […]

Read More